Reducing the Risk of Relapse in Patients with Relapsing Forms of Multiple Sclerosis
Program Overview
This CME program will highlight recent advances in the treatment and management of multiple sclerosis (MS), with a focus on best practices for reducing risk in patients with relapsing forms of MS. The expert faculty will analyze current guidelines and recommendations, highlighting the definitions of MS activity, progression, and worsening. Various emerged and emerging agents for the treatment ...View Course
Advances in the Diagnosis and Treatment of Polyneuropathy of Hereditary Transthyretin-Mediated Amyloidosis in Adults
Program Overview
This CME program is derived from content presented at the Florida Society of Neurology 2019 held in Orlando, Florida on September 13, 2019. The expert faculty will discuss the importance of patient screening, accurate diagnosing, and cross-disciplinary approaches for the management of Hereditary Transthyretin-Mediated Amyloidosis (hATTR). This includes a review the most recent clinical trial data for the ...View Course
Clinical Update of Disease Modifying Therapies for the Management of Parkinson’s Disease
Program Overview
This CME program is derived from content presented at the Florida Society of Neurology 2019 held in Orlando, Florida on September 13, 2019. The expert faculty will provide an overview of current and emerging therapies for the treatment of Parkinson’s disease. This includes an a review of proper patient screenings and novel therapeutic approaches. The faculty will also ...View Course
Integration of Personalized Medicine into the Management of Patients with Multiple Sclerosis
Program Overview
This CME program is derived from content presented at the Florida Society of Neurology 2019 Annual Meeting held in Orlando, Florida. The expert faculty will discuss the importance of personalized treatment strategies to more effectively care for patients with multiple sclerosis. This includes a review of current and emerging therapeutics for the treatment of highly active RRMS. The ...View Course
Applying Newer Advances to Clinical Practice for the Management of Acute Leukemia
Program Overview
This CME/CE activity will provide clinicians with an overview of the novel treatment strategies and management techniques for patients with acute myeloid leukemia (AML) and acute lymphoblastic leukemia (ALL). The three expert faculty will review the pathophysiology of AML and ALL, including the methods used for diagnosing disease and monitoring treatment. An analysis of the latest data for ...View Course
Implementing New Pharmacologic Treatments to Achieve Optimal Outcomes in Patients with Multiple Myeloma
Program Overview
This CME/CE activity will highlight recent data for the treatment and management of multiple myeloma (MM), including information presented at the 2019 American Society of Clinical Oncology Annual Meeting in Chicago, Illinois. The expert faculty, chaired by C. Ola Landgren, MD, PhD, will first discuss the pathophysiology of multiple myeloma, reviewing the skeletal, renal, hematologic and neurologic processes ...View Course
Emerging Science for the Treatment of Parkinson’s Disease
Program Overview
This CME activity will review emerging science for the treatment Parkinson’s disease (PD) as presented at the American Academy of Neurology (AAN) 2019 Annual Meeting in Philadelphia, Pennsylvania. The expert faculty, led by Dr. Daniel Kremens, will review the pathophysiology of Parkinson’s disease in order to diagnose patients early and accurately. The faculty will also analyze the latest ...View Course
An AAN 2019 Multiple Sclerosis Update
Program Overview
This CME/CNE activity will provide a comprehensive update of best practices for treating and managing patients with multiple sclerosis (MS), including data presented at American Academy of Neurology (AAN) 2019 Annual Meeting. The expert faculty will review strategies for early detection and intervention in MS, referencing the McDonald Criteria. Recent clinical trial data, including extension data of emerging ...View Course
Updates on the Assessment and Treatment of Geriatric Patients with Alzheimer’s Disease
Program Overview
This CE symposium will provide clinicians with an overview of the novel treatment strategies for patients with Alzheimer’s disease (AD). Three expert faculty will review recent advances in prevention techniques, diagnostic criteria and clinical assessment for patients with AD. An analysis of clinical trial data for emerging therapeutics to improve outcomes in patients with Alzheimer’s disease will be ...View Course
Applying Efficacy and Safety Science to Develop Individualized Treatment Plans for Patients With Multiple Sclerosis
Program Overview
Advances in the science and clinical trial data for the treatment of patients with multiple sclerosis (MS) continue to evolve at a rapid pace. This continuing education program, derived from content presented at the 2019 Consortium of Multiple Sclerosis Centers Meeting, will bring healthcare professionals up-to-date on recent treatment and management strategies in MS, including S1P based therapies ...View Course
